[{"uuid": "41533e72-579f-4537-a942-f215d54210f5", "publishTime": "2021-10-05T10:44:15.000Z", "title": "SCOTUS denies review of IP cases involving Biogen, Illumina, Nintendo", "description": "The U.S. Supreme Court rejected several intellectual property-related petitions on Monday, including the following:", "assetTags": ["Biogen Inc", "BIIB NASDAQ", "BIIB US"], "searchTags": ["BIIB"], "category": "major_publication", "url": "https://www.reuters.com/legal/government/scotus-denies-review-ip-cases-involving-biogen-illumina-nintendo-2021-10-04/?utm_campaign=cityfalcon&utm_medium=cityfalcon&utm_source=cityfalcon", "imageUrls": ["https://www.reuters.com/resizer/HuKU9vGYF_yptrryprOBr4t-VQg=/1200x628/smart/filters:quality(80)/cloudfront-us-east-2.images.arcpublishing.com/reuters/OOJUEESLMJNR7HDD5TAFOA7W34.jpg"], "lang": "en", "cityfalconScore": 61, "additionalData": {}, "source": {"name": "reuters.com", "brandName": "Reuters", "imageUrl": "https://cityfalconproduction.blob.core.windows.net/autotweetmedia/domains/logos/1652606/small.png", "imageUrls": {"thumb": "https://cityfalconproduction.blob.core.windows.net/autotweetmedia/domains/logos/1652606/thumb.png", "small": "https://cityfalconproduction.blob.core.windows.net/autotweetmedia/domains/logos/1652606/small.png", "medium": "https://cityfalconproduction.blob.core.windows.net/autotweetmedia/domains/logos/1652606/medium.png", "large": "https://cityfalconproduction.blob.core.windows.net/autotweetmedia/domains/logos/1652606/large.png"}}, "duplicatesCount": 2, "paywall": false, "registrationRequired": false, "cityfalcon_permalink": "https://www.cityfalcon.com/news/directory/stocks/biogen-inc-biib"}, {"uuid": "983f779e-6d30-429e-89ec-fe4c332fbcb3", "publishTime": "2021-09-20T12:20:54.000Z", "title": "U.S. FDA approves first biosimilar rival to Roche's blockbuster eye drug", "description": "The U.S. Food and Drug Administration on Monday approved South Korean drugmaker Samsung Bioepis Co Ltd and Biogen Inc's biosimilar rival to Roche Holding AG's blockbuster eye drug, Lucentis.", "assetTags": ["Biogen Inc", "BIIB NASDAQ", "BIIB US"], "searchTags": ["BIIB"], "category": "major_publication", "url": "https://www.reuters.com/business/healthcare-pharmaceuticals/us-fda-approves-first-biosimilar-rival-roches-blockbuster-eye-drug-2021-09-20/?utm_campaign=cityfalcon&utm_medium=cityfalcon&utm_source=cityfalcon", "imageUrls": ["https://www.reuters.com/resizer/-aH9oivrs0Zy_FghMBtTP_qfLDM=/1200x628/smart/filters:quality(80)/cloudfront-us-east-2.images.arcpublishing.com/reuters/BD5K2CF4GRPRHETPBE3BAELBIU.jpg"], "lang": "en", "cityfalconScore": 47, "additionalData": {}, "source": {"name": "reuters.com", "brandName": "Reuters", "imageUrl": "https://cityfalconproduction.blob.core.windows.net/autotweetmedia/domains/logos/1652606/small.png", "imageUrls": {"thumb": "https://cityfalconproduction.blob.core.windows.net/autotweetmedia/domains/logos/1652606/thumb.png", "small": "https://cityfalconproduction.blob.core.windows.net/autotweetmedia/domains/logos/1652606/small.png", "medium": "https://cityfalconproduction.blob.core.windows.net/autotweetmedia/domains/logos/1652606/medium.png", "large": "https://cityfalconproduction.blob.core.windows.net/autotweetmedia/domains/logos/1652606/large.png"}}, "duplicatesCount": 38, "paywall": false, "registrationRequired": false, "cityfalcon_permalink": "https://www.cityfalcon.com/news/directory/stocks/biogen-inc-biib"}, {"uuid": "f1a9a84c-1182-49cc-a7bc-862181f1ff60", "publishTime": "2021-10-15T10:52:00.000Z", "title": ": Biogen stock price target cut to $344 from $430 at Stifel Nicolaus", "description": "This is a Real-time headline. These are breaking news, delivered the minute it happens, delivered ticker-tape style. Visit www.marketwatch.com or the quote page for more information about this breaking news.", "assetTags": ["Biogen Inc", "BIIB NASDAQ", "BIIB US"], "searchTags": ["BIIB"], "category": "major_publication", "url": "https://feeds.marketwatch.com/~r/marketwatch/realtimeheadlines/~3/cu4JLqkhvQg/quotes.asp?utm_campaign=cityfalcon&utm_medium=cityfalcon&utm_source=cityfalcon", "imageUrls": null, "lang": "en", "cityfalconScore": 47, "additionalData": {}, "source": {"name": "marketwatch.com", "brandName": "MarketWatch", "imageUrl": "https://cityfalconproduction.blob.core.windows.net/autotweetmedia/domains/logos/3682/small.png", "imageUrls": {"thumb": "https://cityfalconproduction.blob.core.windows.net/autotweetmedia/domains/logos/3682/thumb.png", "small": "https://cityfalconproduction.blob.core.windows.net/autotweetmedia/domains/logos/3682/small.png", "medium": "https://cityfalconproduction.blob.core.windows.net/autotweetmedia/domains/logos/3682/medium.png", "large": "https://cityfalconproduction.blob.core.windows.net/autotweetmedia/domains/logos/3682/large.png"}}, "duplicatesCount": 0, "paywall": false, "registrationRequired": false, "cityfalcon_permalink": "https://www.cityfalcon.com/news/directory/stocks/biogen-inc-biib"}, {"uuid": "0ddfc650-41cf-48d4-9b97-9eb2bcc33298", "publishTime": "2021-09-23T10:03:25.000Z", "title": "Needham gives Biogen a buy rating, predicts big rally despite controversy around Alzheimer's drug", "description": "The rollout of Aduhelm is facing \"near-term challenges,\" according to Biogen.", "assetTags": ["Biogen Inc", "BIIB NASDAQ", "BIIB US"], "searchTags": ["BIIB"], "category": "major_publication", "url": "https://www.cnbc.com/2021/09/23/needham-gives-biogen-a-buy-rating-predicts-big-rally-despite-controversy-around-alzheimers-drug.html?utm_campaign=cityfalcon&utm_medium=cityfalcon&utm_source=cityfalcon", "imageUrls": ["https://image.cnbcfm.com/api/v1/image/106936821-1630602069094-biogen.jpg?v=1630602124"], "lang": "en", "cityfalconScore": 42, "additionalData": {}, "source": {"name": "cnbc.com", "brandName": "CNBC", "imageUrl": "https://cityfalconproduction.blob.core.windows.net/autotweetmedia/domains/logos/1665829/small.png", "imageUrls": {"thumb": "https://cityfalconproduction.blob.core.windows.net/autotweetmedia/domains/logos/1665829/thumb.png", "small": "https://cityfalconproduction.blob.core.windows.net/autotweetmedia/domains/logos/1665829/small.png", "medium": "https://cityfalconproduction.blob.core.windows.net/autotweetmedia/domains/logos/1665829/medium.png", "large": "https://cityfalconproduction.blob.core.windows.net/autotweetmedia/domains/logos/1665829/large.png"}}, "duplicatesCount": 13, "paywall": false, "registrationRequired": false, "cityfalcon_permalink": "https://www.cityfalcon.com/news/directory/stocks/biogen-inc-biib"}, {"uuid": "42d51134-6e2e-4327-88cc-f7040a2f5678", "publishTime": "2021-09-22T14:04:00.000Z", "title": "Biogen Stock Is Down on a Report That Few Have Received Its New Alzheimer\u2019s Therapy", "description": "Biogen stock is falling on a report that only around 100 patients have received its approved Alzheimer's treatment Aduhelm as of Sept. 11.", "assetTags": ["Biogen Inc", "BIIB NASDAQ", "BIIB US"], "searchTags": ["BIIB"], "category": "major_publication", "url": "https://www.marketwatch.com/articles/biogen-stock-down-alzheimers-51632319432?utm_campaign=cityfalcon&utm_medium=cityfalcon&utm_source=cityfalcon", "imageUrls": ["https://images.barrons.com/im-405001/social"], "lang": "en", "cityfalconScore": 41, "additionalData": {}, "source": {"name": "marketwatch.com", "brandName": "MarketWatch", "imageUrl": "https://cityfalconproduction.blob.core.windows.net/autotweetmedia/domains/logos/3682/small.png", "imageUrls": {"thumb": "https://cityfalconproduction.blob.core.windows.net/autotweetmedia/domains/logos/3682/thumb.png", "small": "https://cityfalconproduction.blob.core.windows.net/autotweetmedia/domains/logos/3682/small.png", "medium": "https://cityfalconproduction.blob.core.windows.net/autotweetmedia/domains/logos/3682/medium.png", "large": "https://cityfalconproduction.blob.core.windows.net/autotweetmedia/domains/logos/3682/large.png"}}, "duplicatesCount": 0, "paywall": false, "registrationRequired": false, "cityfalcon_permalink": "https://www.cityfalcon.com/news/directory/stocks/biogen-inc-biib"}, {"uuid": "e5033ef0-1806-46e0-a946-719a215bbab1", "publishTime": "2021-09-24T15:47:00.000Z", "title": "Biogen\u2019s Aduhelm Struggles Don\u2019t Hurt Lilly\u2019s Outlook, Says Analyst", "description": "Lilly's experimental Alzheimer's therapy, donanemab, still has a \u201ctransformational growth opportunity,\u201d despite Biogen's embattled rollout of Aduhelm, says...", "assetTags": ["Biogen Inc", "BIIB NASDAQ", "BIIB US"], "searchTags": ["BIIB"], "category": "major_publication", "url": "https://www.marketwatch.com/articles/biogen-lilly-stock-51632498379?utm_campaign=cityfalcon&utm_medium=cityfalcon&utm_source=cityfalcon", "imageUrls": ["https://images.barrons.com/im-406456/social"], "lang": "en", "cityfalconScore": 40, "additionalData": {}, "source": {"name": "marketwatch.com", "brandName": "MarketWatch", "imageUrl": "https://cityfalconproduction.blob.core.windows.net/autotweetmedia/domains/logos/3682/small.png", "imageUrls": {"thumb": "https://cityfalconproduction.blob.core.windows.net/autotweetmedia/domains/logos/3682/thumb.png", "small": "https://cityfalconproduction.blob.core.windows.net/autotweetmedia/domains/logos/3682/small.png", "medium": "https://cityfalconproduction.blob.core.windows.net/autotweetmedia/domains/logos/3682/medium.png", "large": "https://cityfalconproduction.blob.core.windows.net/autotweetmedia/domains/logos/3682/large.png"}}, "duplicatesCount": 0, "paywall": false, "registrationRequired": false, "cityfalcon_permalink": "https://www.cityfalcon.com/news/directory/stocks/biogen-inc-biib"}, {"uuid": "21a3a500-83f8-4ba9-a962-474d2f3bb1e7", "publishTime": "2021-09-17T20:40:00.000Z", "title": "Biogen Inc. stock outperforms market on strong trading day", "description": "Shares of Biogen Inc. inched 0.17% higher to $300.19 Friday, on what proved to be an all-around poor trading session for the stock market, with the S&P 500...", "assetTags": ["Biogen Inc", "BIIB NASDAQ", "BIIB US"], "searchTags": ["BIIB"], "category": "major_publication", "url": "https://www.marketwatch.com/story/biogen-inc-stock-outperforms-market-on-strong-trading-day-01631911206-fb2af7b8c0c9?utm_campaign=cityfalcon&utm_medium=cityfalcon&utm_source=cityfalcon", "imageUrls": ["https://images.mktw.net/im-220105/social"], "lang": "en", "cityfalconScore": 35, "additionalData": {}, "source": {"name": "marketwatch.com", "brandName": "MarketWatch", "imageUrl": "https://cityfalconproduction.blob.core.windows.net/autotweetmedia/domains/logos/3682/small.png", "imageUrls": {"thumb": "https://cityfalconproduction.blob.core.windows.net/autotweetmedia/domains/logos/3682/thumb.png", "small": "https://cityfalconproduction.blob.core.windows.net/autotweetmedia/domains/logos/3682/small.png", "medium": "https://cityfalconproduction.blob.core.windows.net/autotweetmedia/domains/logos/3682/medium.png", "large": "https://cityfalconproduction.blob.core.windows.net/autotweetmedia/domains/logos/3682/large.png"}}, "duplicatesCount": 0, "paywall": false, "registrationRequired": false, "cityfalcon_permalink": "https://www.cityfalcon.com/news/directory/stocks/biogen-inc-biib"}, {"uuid": "b02663e7-29f4-4bbc-a144-ad81be188574", "publishTime": "2021-09-19T19:03:00.000Z", "title": "Nike, Costco, FedEx, Salesforce, and Other Stocks to Watch This Week", "description": "Earnings this week come from Nike, Adobe, FedEx, Costco, and more. Salesforce, Weyerhaeuser, and Biogen host investor days. Plus, a FOMC meeting and housing...", "assetTags": ["Biogen Inc", "BIIB NASDAQ", "BIIB US"], "searchTags": ["BIIB"], "category": "major_publication", "url": "https://www.marketwatch.com/articles/stocks-to-watch-this-week-51631934057?utm_campaign=cityfalcon&utm_medium=cityfalcon&utm_source=cityfalcon", "imageUrls": ["https://images.barrons.com/im-385538/social"], "lang": "en", "cityfalconScore": 34, "additionalData": {}, "source": {"name": "marketwatch.com", "brandName": "MarketWatch", "imageUrl": "https://cityfalconproduction.blob.core.windows.net/autotweetmedia/domains/logos/3682/small.png", "imageUrls": {"thumb": "https://cityfalconproduction.blob.core.windows.net/autotweetmedia/domains/logos/3682/thumb.png", "small": "https://cityfalconproduction.blob.core.windows.net/autotweetmedia/domains/logos/3682/small.png", "medium": "https://cityfalconproduction.blob.core.windows.net/autotweetmedia/domains/logos/3682/medium.png", "large": "https://cityfalconproduction.blob.core.windows.net/autotweetmedia/domains/logos/3682/large.png"}}, "duplicatesCount": 0, "paywall": false, "registrationRequired": false, "cityfalcon_permalink": "https://www.cityfalcon.com/news/directory/stocks/biogen-inc-biib"}]